1476
S. Saisin et al.
CH2Cl2, MeOH : CH2Cl2 (10 : 90 ! 50 : 50), MeOH, yielding seven fractions labelled ‘F1’
to ‘F7’. Fraction F2 was purified on silica gel CC using CH2Cl2, MeOH : CH2Cl2,
(5 : 95 ! 50 : 50) and MeOH, to afford six fractions, labelled ‘G1’ to ‘G6’. Fraction G3 was
subsequently purified on silica gel CC using MeOH : CH2Cl2, (0 : 100 ! 100 : 0) to afford
5,7,20-trihydroxy-50-methoxyflavone (1, 30 mg). A portion of fraction G4 (21 g) was
purified on silica gel CC using CH2Cl2, MeOH : CH2Cl2, (0 : 100 ! 100 : 0) and further
purified on Sephadex LH 20 using MeOH : CH2Cl2 (50 : 50) to give resveratol (3, 200 mg)
and 3-methoxyresveratol (4, 600 mg). Fraction G5 was purified on silica gel CC using
CH2Cl2, MeOH : CH2Cl2, (0 : 100 ! 100 : 0) and further purified on Sephadex LH 20 using
MeOH : CH2Cl2 (50 : 50) to give 5,7,40-trihydroxy-30-methoxyflavanone (2, 12 mg) and
shegansu B (5, 80 mg). Fraction F3 was purified on silica gel CC using CH2Cl2,
MeOH : CH2Cl2, (5 : 95 ! 50 : 50), MeOH to afford seven fractions, labelled ‘H1’ to ‘H7’.
Fraction H4 was purified on Sephadex LH 20 using MeOH : CH2Cl2 (50 : 50) to afford
gnetulin (6, 25 mg), gnetuhainin C (7, 35 mg), parvifolol B (8, 20 mg) and pallidol
(9, 11 mg).
5,7,20-Trihydroxy-50-methoxyflavone (1): Amorphous yellow solid; m.p. 269ꢀC (dec); UV
(MeOH) ꢁmax (log ") 227 (3.09), 270 (2.93), 345 (3.06); IR (KBr) 3347, 3082, 1647, 1621,
1
1517, 1347, 1269, 1204, 1165, 826 cmꢁ1; H NMR (DMSO-d6, 400 MHz) and 13C NMR
(DMSO-d6, 100 MHz), see Table 2; HRESIMS m/z [M þ Na]þ 323.0517 (Calcd for C16
H12O6Na, 323.0526).
3.4. Preparation of methyl ethers of 1
Compound 1 (10 mg), dissolved in MeOH (2 mL), was added drop wise to 2.0 M
trimethylsilyldiazomethane (TMSCHN2) in hexane until yellow solution persisted. The
mixture was stirred at room temperature for 1 h. After the reaction mixture was
evaporated to dryness, the residue was purified on preparative TLC developed with 5 : 95
MeOH : CH2Cl2 to afford 1a (7 mg), 1b (2 mg) and 1c (2 mg).
1
1a: Yellow powder; H NMR (CDCl3) ꢀ 12.90 (1H, 5-OH), 3.86 (3H, s), 3.84 (3H, s),
3.79 (3H, s), 6.13 (1H, d, 2.0), 6.43 (1H, d, 2.0), 6.60 (1H, s), 7.03 (1H, d, 8.4), 7.55 (1H, d,
8.4), 7.50 (1H, s).
1
1b: Yellow powder; H NMR (CDCl3) ꢀ 12.90 (1H, 5-OH), 3.80 (3H, s), 3.82 (3H, s),
6.20 (1H, d, 2.0), 6.60 (1H, d, 2.0), 6.65 (1H, s), 7.05 (1H, d, 8.4), 7.60 (1H, d, 8.4),
7.50 (1H, s).
1
1c: Yellow powder; H NMR (CDCl3) ꢀ 12.90 (1H, 5-OH), 3.80 (3H, s), 3.85 (3H, s),
6.20 (1H, d, 2.0), 6.59 (1H, d, 2.0), 6.65 (1H, s), 6.90 (1H, d, 8.4), 7.50 (1H, d, 8.4),
7.55 (1H, s).
3.5. DPPH radical scavenging
Radical scavenging activity of the isolated compounds was validated using DPPH
colorimetric method (Phuwapraisirisan, Udomchotphruet, Surapinit, & Tip-pyang, 2006;
Wiboonpun, Phuwapraisirisan, & Tip-pyang, 2004). Briefly, a sample solution (0.25 mM,
0.5 mL) was added to 1 mL methanolic solution of DPPH (final concentration
of DPPH was 0.3 mM). The mixture was vigorously shaken and kept in the dark
for 30 min. The absorbance of the resulting solution was measured at 518 nm with a
UV spectrometer.